Addiction

The CDC concluded that by 2021, the "rate of drug overdose deaths involving xylazine was 35 times higher than the 2018 rate."

New Jersey lawmakers are going after fentanyl manufacturers and distributors to solve the state’s opioid crisis.

Xylazine is being mixed into fentanyl across the U.S., but who's doing it and why is a mystery. The government still doesn't identify and track new drug threats.

Over the course of the next 18 years, Delco will receive $63 million in settlement payments. Now comes the tough part. What should Delco spend the money on?

Philly takes first steps in distributing national opioid settlement funds with $1.9 million in grants for community and grassroots organizations.

The user wanted fentanyl, and paid with his life. Advocates and law enforcement agents agree the case illustrates the escalating dangers of fake pills.

Julius BaDour lost his job, quit his relationship, and left his hometown to live a life on the road. He learned some lessons about quitting along the way.

The nonprofit is teaming up with three hospital systems to provide people a direct path from the emergency room to supportive housing.

Under the plan, members of the wealthy Sackler family would give up ownership of Stamford, Connecticut-based Purdue, with its profits being used to fight the opioid crisis.

There’s currently no single resource for people to see how counties and local governments plan to spend the money. But understanding the process can help you influence it.

THC levels in cannabis on today's market are more potent than decades ago, leaving many parents worried about their teen's developing brains. Rutgers' Danielle Dick joins us.

Several City Council members want to preemptively ban such sites in residential neighborhoods in certain parts of the city.

Sen. Nikil Saval, D-Philadelphia, said efforts to ban the centers are based on misconceptions that they provide drugs or contribute to crime.

CHANCES was an outpatient substance use treatment program in Philly. It initially opened in the early '90s to serve women and mothers.

Telehealth providers say the Biden administration should reconsider proposed regulations that would make obtaining prescription controlled drugs harder.